Editas Medicine Statistics
Total Valuation
EDIT has a market cap or net worth of $236.85 million. The enterprise value is $10.25 million.
Important Dates
The last earnings date was Monday, November 4, 2024, before market open.
| Earnings Date | Nov 4, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
EDIT has 82.24 million shares outstanding. The number of shares has increased by 13.03% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 82.24M |
| Shares Change (YoY) | +13.03% |
| Shares Change (QoQ) | +0.21% |
| Owned by Insiders (%) | 0.39% |
| Owned by Institutions (%) | 61.27% |
| Float | 75.91M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.83 |
| Forward PS | 8.66 |
| PB Ratio | 1.35 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.17 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.75, with a Debt / Equity ratio of 0.22.
| Current Ratio | 3.75 |
| Quick Ratio | 3.67 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -78.56% and return on invested capital (ROIC) is -46.89%.
| Return on Equity (ROE) | -78.56% |
| Return on Assets (ROA) | -34.32% |
| Return on Capital (ROIC) | -46.89% |
| Revenue Per Employee | $233,053 |
| Profits Per Employee | -$794,611 |
| Employee Count | 265 |
| Asset Turnover | 0.15 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -65.34% in the last 52 weeks. The beta is 2.00, so EDIT's price volatility has been higher than the market average.
| Beta (5Y) | 2.00 |
| 52-Week Price Change | -65.34% |
| 50-Day Moving Average | 3.44 |
| 200-Day Moving Average | 5.52 |
| Relative Strength Index (RSI) | 36.74 |
| Average Volume (20 Days) | 2,070,780 |
Short Selling Information
The latest short interest is 18.33 million, so 22.29% of the outstanding shares have been sold short.
| Short Interest | 18.33M |
| Short Previous Month | 16.74M |
| Short % of Shares Out | 22.29% |
| Short % of Float | 24.15% |
| Short Ratio (days to cover) | 8.19 |
Income Statement
In the last 12 months, EDIT had revenue of $61.76 million and -$210.57 million in losses. Loss per share was -$2.56.
| Revenue | 61.76M |
| Gross Profit | -70.77M |
| Operating Income | -228.52M |
| Pretax Income | -193.45M |
| Net Income | -210.57M |
| EBITDA | -222.63M |
| EBIT | -228.52M |
| Loss Per Share | -$2.56 |
Full Income StatementBalance Sheet
The company has $265.09 million in cash and $38.49 million in debt, giving a net cash position of $226.60 million or $2.76 per share.
| Cash & Cash Equivalents | 265.09M |
| Total Debt | 38.49M |
| Net Cash | 226.60M |
| Net Cash Per Share | $2.76 |
| Equity (Book Value) | 175.63M |
| Book Value Per Share | 2.13 |
| Working Capital | 198.79M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$181.76 million and capital expenditures -$9.59 million, giving a free cash flow of -$191.36 million.
| Operating Cash Flow | -181.76M |
| Capital Expenditures | -9.59M |
| Free Cash Flow | -191.36M |
| FCF Per Share | -$2.33 |
Full Cash Flow StatementMargins
| Gross Margin | -114.59% |
| Operating Margin | -370.02% |
| Pretax Margin | -340.96% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -255.91% |